A PARP inhibitor: olaparib
FAN Li-ping;JIAO Yuan-yuan;LI Ran;GUO Zi-han;ZHANG Yan-hua;Key Laboratory of Carcinogenesis and Translational Research;Department of Pharmacy;Peking University Cancer Hospital & Institute;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University Health Science Center;

..............page:1321-1325

Research progress and development direction of bio-pharmaceutical industry technology innovation alliance network
WANG Qi-qi;MAO Ning-ying;School of International Pharmaceutical Business of CPU;China Pharmaceutical University;

..............page:1326-1331

The research on technological innovation strategy to enhance corporation growth capability in the perspective of patent licensing
LI Lin-ke;DENG Fei-fei;YUAN Hong-mei;YANG Shu-jie;College of Business Administration;Shenyang Pharmaceutical University;

..............page:1332-1338

Influence of phospholipid components on the quality of lipid emulsions
SONG Hua-xian;LIN Jin-ping;LIN Jing-wen;HUA Kun;WANG Yan-ju;Beijing Land Medical Technology Co.;Ltd.;

..............page:1339-1342

Zebrafish used in toxic target organ studies of Chinese herbs
ZHANG Yong;GUO Sheng-ya;DENG Zhong-ping;LI Chun-qi;Hunter Biotechnology;Inc;Center for Drug Safety Evaluation and Research;Shanghai University of Traditional Chinese Medicine;Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals;

..............page:1343-1347

Research progress of toxicity pathways and molecular initiating events in drug-induced liver injury
JING Xiao;WU Chun-qi;WANG Xi-sha;WANG Quan-jun;School of Chinese Material Medica;Guangdong Pharmaceutical University;National Beijing Center for Drug Safety Evaluation and Research;State Key Laboratory of Medical Countermeasures and Toxicology;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;

..............page:1348-1354

Antithrombotic activity of Formononetin sodium and its mechanism
WAN Yan-jun;ZHUANG Peng-wei;ZHANG Yan-jun;Tianjin University of Traditional Chinese Medicine;Tianjin Key Laboratory of Pharmacology of Chinese Materia Medica;

..............page:1355-1358

Research progress of the dosage form improvement and administration mode of triptolide
YU Ya-ting;ZHU Wei-feng;JIN Chen;CHEN Li-hua;GUAN Yong-mei;Key Laboratory of Modern Preparation of TCM;Ministry of Education;Jiangxi University of Traditional Chinese Medicine;Jiangxi Province Research Center of Extracts and Preparations Engineering Technology of TCM;

..............page:1359-1362

Development of antiplatelet agents for thrombotic diseases
HAN Cong-fan;FENG Wen-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:1363-1369

An overview of long-acting contraceptives and devices
ZENG Jia;QIU Nian-ping;LI Fang;PAN Feng;LIU Dan-ping;FENG Ling-lin;Shanghai Institute of Planned Parenthood Research;Key Laboratory of Contraceptives and Devices Research;Shanghai Engineer and Technology Research Center of Reproductive Health Drug and Devices;Beijing Increase Pharmaceutical Institute Co.;Ltd.;Guangxi University of Traditional Chinese Medicine;College of Pharmacy;

..............page:1370-1377

Component difference between traditional decotion and formula granules decoction of traditional Chinese medicine berberine
WANG Qing-xiao;WANG Chong;LIU Rui-xin;WANG Pan-pan;GAO Xiao-jie;GUI Xin-jing;MENG Xiang-le;LI Xue-lin;Food and Drug Control of Henan Province;National Institutes for Food and Drug Control;Department of Pharmacy;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine;Henan University of Traditional Chinese Medicine;

..............page:1378-1384

A comprehensive evaluation of the masking effect of traditional Chinese medicine companion based on ISEM and FSEM
KANG Bing-ya;LIU Rui-xin;MENG Xiang-le;SHI Jun-han;ZHANG lu;GAO Xiao-jie;GUI Xin-jing;LI Xue-lin;The First Affiliated Hospital of Henan Traditional Chinese Medicine University;Henan University of Traditional Chinese Medicine;

..............page:1385-1390

Analysis of complete information static game of the main stakeholders of clinical trials
YANG Fan;WANG Meng-yuan;TAO Tian-tian;YAO Wen-bing;SHAO Rong;National Drug Policy and Medical Industry Economy Research Center of China Pharmaceutical University;

..............page:1391-1395

The legal relationship between sponsors and other bodies of drug clinical trials
YANG Fan;TAO Tian-tian;WANG Meng-yuan;YAO Wen-bing;SHAO Rong;National Drug Policy and Medical Industry Economy Research Center of China Pharmaceutical University;

..............page:1396-1400

Uncertainty evaluation of determination of vancomycin in human cerebrospinal fluid by HPLC
WANG Jia-qing;ZHAO Zhi-gang;MEI Sheng-hui;Department of Pharmacy;Beijing Tiantan Hospital;Capital Medical University;

..............page:1401-1406

Treatment of post-infection irritable bowel with rifaximin combined with lactobacillus complex capsules
JI Meng-chen;CUI Li-hong;Affiliated Clinical Faculty of Navy General Hospital;Anhui Medical University;Department of Gastroenterology;Navy General Hospital;

..............page:1407-1412

The clinical efficacy of domestic escitalopram tablets on endothelial function and cardiovascular events in chronic ischemia heart failure patients with depressive disorder
ZHAO Qing-zhen;LIU Gang;LIU Chao;Department of Cardiology;the First Affiliated Hospital of Hebei Medical University;

..............page:1413-1416

Design,synthesis and activities of specific urate transporter inhibitors: benzofuran derivatives containing carboxyl groups
DONG Shuai;CHEN Jia-sheng;WU Ting;QIU Yu-chang;CAO Ying;PANG Jian-xin;XI Bao-min;Guangdong Provincial Key Laboratory of New Drug Screening;School of Pharmaceutical Sciences;Southern Medical University;

..............page:1417-1423

Formulation,characterization,and pharmacokinetics of solid lipid nanoparticles loaded with naringenin
BIAN Long-yan;Yancheng Health Vocational and Technical College;

..............page:1424-1430

Analysis of anti-parkinson disease drugs used in 34 hospitals in Nanjing during 2012—2014
LIU Xiao-hua;ZHU Yong-hong;The First Affiliated Hospital with Nanjing Medical University;The Affiliated Hospital of Nantong University;

..............page:1431-1435

The role of clinical pharmacists in the management of respiratory diseases
MA Zhuo;YANG Mei;YANG Hui;SU Ye;LIU Li-hong;Pharmacy Department of Beijing Chao Yang Hospital;Capital Medical University;

..............page:1436-1440